⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EDSA News
Edesa Biotech, Inc. Common Shares
Form 8-K
sec.gov
EDSA
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors
globenewswire.com
EDSA
Form 8-K
sec.gov
EDSA
Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury
globenewswire.com
EDSA
Form 8-K
sec.gov
EDSA
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
globenewswire.com
EDSA
Form 8-K
sec.gov
EDSA
Form 8-K
sec.gov
EDSA
Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results
globenewswire.com
EDSA
Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight
globenewswire.com
EDSA
VERU
PLTR
HLIO
DRCT
BHVN
CART
AMGN
AROW
AZN
GSK
NVS
SNDX
SNY
UNH
VRTX